SEC Form 4 · accession 0001225208-17-017206
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanat Chattopadhyay
Officer — Exe V-P & Pres. MMD
Period of report
Nov 9, 2017
Accepted (ET)
Nov 13, 2017 · 2:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 43,296 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF1,F2 | — | Nov 9, 2017 | I | 13,100 | A | — | — | Common Stock | 13,100 | 13,123 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2Each share of phantom stock is the economic equivalent of one share of Merck common stock and was granted under the Merck & Co., Inc. Deferral Program (the "Program"). The Program includes the right of redesignation to other investment measures within the Program.